Objective To analyze the potential causal relationship between gut microbiota (GM) and two common neurodevelepmentcoldisorders, attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) using Mendelian randomization (MR). Methods A two-sample MR analysis was conducted using publicly available genome-wide association study (GWAS) data to explore the relationship between gut microbiota and ADHD/ASD. Independent genetic loci significantly associated with the relative abundance of 211 gut microbiota taxa were selected as instrumental variables (IVs) based on a predefined threshold (P<10-5). Multiple methods, including the inverse-variance weighted (IVW) method, were employed for analysis, with results evaluated using odds ratios (ORs) and 95% confidence intervals (CIs). Sensitivity analysis, including leave-one-out analysis, heterogeneity testing, and horizontal pleiotropy testing, were performed to ensure the stability and reliability of the results. Results Increased abundance of Desulfovibrio (OR=0.742, 95%CI: 0.595 - 0.925), Porphyromonadaceae (OR＝0.761, 95%CI: 0.585 - 0.989), and Firmicutes (OR＝0.799, 95%CI: 0.646 - 0.988) was associated with a reduced risk of ADHD. In contrast, increased abundance of Bifidobacteriales was identified as a potential risk factor for ADHD (OR＝1.335, 95%CI: 1.111 - 1.605). For ASD, increased abundance of Ruminococcus (OR＝0.778, 95%CI: 0.671 - 0.901), Gram-negative bacillus (OR＝0.821, 95% CI: 0.684 - 0.987), and Gram-positive anaerobic bacteria (OR＝0.811, 95%CI: 0.686 - 0.959) was associated with a reduced risk, while increased abundance of Prevotella was associated with an increased risk of ASD (OR＝1.238, 95%CI: 1.091 - 1.404). Leave-one-out analysis confirmed the stability of the results, with no strong influential IVs detected. Heterogeneity and horizontal pleiotropy were ruled out as confounding factors. Conclusions This study demonstrates a potential causal link between gut microbiota and two common childhood psychiatric disorders, ADHD and ASD. It provides valuable insights into specific microbial taxa that may influence disease risk, offering a foundation for further research and potential therapeutic targets.
Key words
gut microbiota /
Mendelian randomization /
attention-deficit/hyperactivity disorder /
autism spectrum disorder /
causality
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 冯璐,王琳琳.中医疗法与心理疗法相结合治疗学前儿童多动症[J].辽宁中医杂志,2010,37(9):1766-1767.
Feng L, Wang LL. Combining traditional Chinese medicine therapy with psychotherapy for the treatment of preschool children with attention deficit hyperactivity disorder[J].Liaoning Journal of Traditional Chinese Medicine, 2010,37(9):1766-1767.(in Chinese)
[2] 黄娟.学龄期6~11岁注意缺陷多动障碍儿童行为问题分析[D].成都:成都医学院,2023.
Huang J. Analysis of behavioral problems in school-age children (6-11 years old) with attention deficit hyperactivity disorder[D].Chengdu:Chengdu Medical College, 2023.(in Chinese)
[3] Gyawali S, Patra BN. Trends in concept and nosology of autism spectrum disorder: A review[J].Asian J Psychiatr, 2019,40:92-99.
[4] Lasheras I, Seral P, Latorre E, et al. Microbiota and gut-brain axis dysfunction in autism spectrum disorder: Evidence for functional gastrointestinal disorders[J].Asian J Psychiatr, 2020,47:101874.
[5] Habata K, Cheong Y, Kamiya T, et al. Relationship between sensory characteristics and cortical thickness/volume in autism spectrum disorders[J].Transl Psychiatry, 2021,11(1):616.
[6] Gershon MD, Margolis KG. The gut, its microbiome, and the brain:Connections and communications[J].J Clin Invest, 2021,131(18):e143768.
[7] Averina OV, Kovtun AS, Polyakova SI, et al. The bacterial neurometabolic signature of the gut microbiota of young children with autism spectrum disorders[J].J Med Microbiol, 2020,69:558-571.
[8] Arzani M, Jahromi SR, Ghorbani Z, et al. Comprehensive research progress of the gut-brain axis and migraine[J].Headache Pain, 2020,21(1):15.
[9] Wan XK, Yu SC, Mei SQ,et al. Application of mendelian randomization analysis in investigating the genetic background of blood biomarkers for colorectal cancer[J]. Yi Chuan, 2024,46(10):833-848.
[10] Dodhia SA, West NX, Thomas SJ, et al. Examining the causal association between 25-hydroxyvitamin D and caries in children and adults:A two-sample mendelian randomization approach[J].Wellcome Open Res, 2021,5:281.
[11] Yang H, Jin C, Li J, et al. Causal relationship between bladder cancer and gutmicrobiota contributes to the gut-bladder axis: A two-sample mendelian randomization study[J].Urol Oncol, 2024. doi:10.1016/j.urolonc.2024.10.014.
[12] Shin H. XGBoost regression of the most significantphotoplethysmogram features for assessing vascular aging[J].IEEE J Biomed Health Inform, 2022,26(7):3354-3361.
[13] Xie F, Feng Z, Xu B. Metaboliccharacteristics of gut microbiota and insomnia: Evidence from a mendelian randomization analysis[J].Nutrients, 2024,16(17):2943.
[14] Xiang Y, Zhang C, Wang J, et al. Identification of host gene-microbiome associations in colorectal cancer patients usingmendelian randomization[J].J Transl Med, 2023,21(1):535.
[15] Bowden J, Davey Smith G, Haycock PC, et al. Consistent estimation inmendelian randomization with some invalid instruments using a weighted median estimator[J].Genet Epidemiol, 2016,40(4):304-314.
[16] Mao D, Tao B, Sheng S, et al. Causaleffects of gut microbiota on age-related macular degeneration: A mendelian randomization study[J].Invest Ophthalmol Vis Sci, 2023,64(12):32.
[17] Gala H, Tomlinson I. The use of mendelian randomisation to identify causal cancer risk factors: Promise and limitations[J].J Pathol, 2020,250(5):541-554.
[18] Li K, Liu P, Wang X, et al. Causal role of gut microbiota, serum metabolites, immunophenotypes in myocarditis: A mendelian randomization study[J].Front Genet, 2024,15:1382502.
[19] Kurilshikov A, Medina-Gomez C, Bacigalupe R, et al. Large-scale association analyses identify host factors influencing human gut microbiome composition[J].Nat Genet, 2021,53(2):156-165.
[20] Korver DR. Intestinal nutrition: Role of vitamins and biofactors and gaps of knowledge[J].Poult Sci, 2022;101(4):101665.
[21] Pärtty A, Kalliomäki M, Wacklin P, et al. A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: A randomized trial[J].Pediatr Res, 2015,77:823-828.
[22] Clemente JC, Ursell LK,Parfrey LW, et al. The impact of the gut microbiota on human health: An integrative view[J].Cell, 2012,148(6):1258-1270.
[23] Bravo JA, Forsythe P, Chew MV, et al. Ingestion oflactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve[J].Proc Natl Acad Sci USA, 2011,108:16050-16055.
[24] Saurman V, Margolis KG, Luna RA. Autism spectrum disorder as a brain-gut-microbiome axis disorder[J].Dig Dis Sci, 2020,65(3):818-828.
[25] Parada Venegas D, De la Fuente MK, Landskron G, et al. Shortchain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases[J].Front Immunol, 2019,10:277.
[26] Silva YP, Bernardi A, Frozza RL. Therole of short-chain fatty acids from gut microbiota in gut-brain communication[J].Front Endocrinol (Lausanne), 2020,11:25.
[27] Botti G, Dalpiaz A, Pavan B. Targetingsystems to the brain obtained by merging prodrugs, nanoparticles, and nasal administration[J].Pharmaceutics, 2021,13(8):1144.
[28] Mackintosh AJ,de Bock R, Lim Z, et al. Psychotic disorders, dopaminergic agents and EEG/MEG resting-state functional connectivity: A systematic review[J].Neurosci Biobehav Rev, 2021,120:354-371.
[29] Eickhoff S, Franzen L, Korda A, et al. Thebasal forebrain cholinergic nuclei and their relevance to schizophrenia and other psychotic disorders[J].Front Psychiatry, 2022,13:909961.
[30] Xia G, Han Y, Meng F, et al. Reciprocal control of obesity and anxiety-depressive disorder via a GABA and serotonin neural circuit[J].Mol Psychiatry, 2021,26(7):2837-2853.
PDF(4291 KB)
